ProCE Banner Activity

CE

Navigating Insulin-Based Therapy for Type 2 Diabetes

Multimedia
Apply new studies on NPH, regular insulin, switching, and other approaches to avoid hypoglycemia, control hyperglycemia, and reduce CV risk with this module.
Registered Nurses : 1.00 Nursing contact {hour}

Released: January 11, 2019

Expiration: January 10, 2020

No longer available for credit.

Share

Faculty

Veronica K. Piziak

Veronica K. Piziak, MD, PhD, FACP

Clinical Professor of Medicine
Department of Medicine
Baylor Scott and White and Texas A&M College of Medicine
Temple, Texas

Provided by

Provided by Southern Medical Association
ProCE Banner

Supporters

Supported by an educational grant from

Lilly USA

Target Audience

This program is intended for endocrinologists, cardiologists, primary care physicians, hospitalists, physician assistants, nurse practitioners, pharmacists, certified diabetes educators, and other healthcare providers who care for patients with type 2 diabetes.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Apply key learnings from T2DM published guidelines and pivotal clinical study results to develop strategies for intensifying therapy in patients who fail to achieve glycemic control on initial therapy
  • Consider findings of cardiovascular outcomes trials when selecting T2DM regimens for patients with elevated cardiovascular risk

Program Director Disclosure

Program Director

Veronica K. Piziak, MD, PhD, FACP

Clinical Professor of Medicine
Department of Medicine
Baylor Scott and White and Texas A&M College of Medicine
Temple, Texas

Veronica K. Piziak, MD, PhD, FACP, has no real or apparent conflicts of interest to report.

Staff Disclosure

Staff

Tanja Link, PhD

Editorial Contributor

Tanja Link, PhD, has no real or apparent conflicts of interest to report.

Megan K. Murphy, PhD

Scientific Director

Megan K. Murphy, PhD, has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no real or apparent conflicts of interest to report.

Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no real or apparent conflicts of interest to report.

Instructions for Credit

Credit Designation

1.0 contact hour may be earned for successful completion of this activity.

Accreditation Statement

This continuing nursing education activity was approved by the Alabama State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 11, 2019, through January 10, 2020:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve participants’ clinical competence in preventing T2DM and at applying culturally competent treatment strategies in the management of patients with T2DM and associated cardiovascular risks.